ライフサイエンスコーパス: fluorescent in situ hybridization

1 e (3+ by immunohistochemistry or positive by fluorescent in situ hybridization).

2 /KRAS wild type and ALK and ROS1 negative by fluorescent in situ hybridization).

3 EGFR gene copy number was assessed by fluorescent in situ hybridization.

4 ngths were measured by telomere quantitative fluorescent in situ hybridization.

5 hromosome was identified in isolated SECs by fluorescent in situ hybridization.

6 HER2 amplification was determined by fluorescent in situ hybridization.

7 intracellular labeling and tyramide-coupled fluorescent in situ hybridization.

8 r coding regions, and for microdeletions, by fluorescent in situ hybridization.

9 stantially with nascent transcript multiplex fluorescent in situ hybridization.

10 chaeal cells at these sites was confirmed by fluorescent in situ hybridization.

11 -like T cell lymphoma without 13q loss using fluorescent in situ hybridization.

12 ned by quantitative image analysis following fluorescent in situ hybridization.

13 ch phylogenetic cluster were confirmed using fluorescent in situ hybridization.

14 th telomeric DNA localization established by fluorescent in situ hybridization.

15 the deletion chromosomes were determined by fluorescent in situ hybridization.

16 Tissue distribution of mRNA was assayed by fluorescent in situ hybridization.

17 mphoma kinase translocation was evaluated by fluorescent in situ hybridization.

18 tinal symbiont Epulopiscium sp. type B using fluorescent in situ hybridization.

19 lable tumors were tested for p16 and EGFR by fluorescent in situ hybridization.

20 quantitative polymerase chain reaction, and fluorescent in situ hybridization.

21 from plasmids in Escherichia coli using RNA fluorescent in-situ hybridization.

22 rome patients without detectable deletion by fluorescent in-situ hybridization.

23 growth factor receptor (EGFR) copy number by fluorescent in situ hybridization (374 assessable sample

24 al abnormalities (CA) detected by interphase fluorescent in situ hybridization after CD138 plasma cel

25 astric mucosa using immunohistochemistry and fluorescent in situ hybridization analyses of gastric ti

26 Interphase fluorescent in situ hybridization analyses of the family

27 , pathologically, and genetically, including fluorescent in situ hybridization analyses with commerci

28 In fluorescent in situ hybridization analyses, IFI16 coloca

29 chromosome 17 q23-24 by radiation hybrid and fluorescent in situ hybridization analyses.

30 Fluorescent in situ hybridization analysis indicates tha

31 Fluorescent in situ hybridization analysis localizes the

32 nted region within 8q23-q24 using interphase fluorescent in situ hybridization analysis of paraffin-e

33 Fluorescent in situ hybridization analysis of primary sp

34 Fluorescent in situ hybridization analysis of wild-type

35 terestingly, human versus murine centromeric fluorescent in situ hybridization analysis on the liver

36 Fluorescent in situ hybridization analysis showed integr

37 lantation were also tested with Y chromosome fluorescent in situ hybridization analysis to detect don

38 helium) and were imaged and then examined by fluorescent in situ hybridization analysis to identify m

39 By fluorescent in situ hybridization analysis, the human co

40 ing, nonchimeric YAC clones using sequential fluorescent in situ hybridization analysis.

41 ll genome as determined by Southern blot and fluorescent in situ hybridization analysis.

42 A7 in neurons was independently confirmed by fluorescent in situ hybridization analysis.

43 coccus Cluster 2, respectively, according to fluorescent in situ hybridization and 454 pyrosequencing

44 A methodological approach using fluorescent in situ hybridization and Affymetrix (Santa

45 p14ARF, and p53 mutations were determined by fluorescent in situ hybridization and Affymetrix (Santa

46 d by quantitative polymerase chain reaction, fluorescent in situ hybridization and analysis of matche

47 intact duplication in mice was confirmed by fluorescent in situ hybridization and BAC-based array co

48 Here we show, using immuno-fluorescent in situ hybridization and ChIP, that up to h

49 We have used fluorescent in situ hybridization and immunocytochemistr

50 roaches (allele-specific RNAseq, nascent RNA-fluorescent in situ hybridization and immunofluorescence

51 Using fluorescent in situ hybridization and immunofluorescence

52 With combined fluorescent in situ hybridization and immunofluorescence

53 Triple-labeling fluorescent in situ hybridization and immunofluorescence

54 In the present study, fluorescent in situ hybridization and immunohistochemist

55 EGFR, KRAS mutation, EGFR fluorescent in situ hybridization and immunohistochemist

56 Using an approach that we termed FISHI, fluorescent in situ hybridization and incorporation, we

57 Using fluorescent in situ hybridization and laser scanning con

58 By Southern Blotting, Fluorescent In Situ Hybridization and Long Distance Inve

59 vel as determined by immunohistochemistry or fluorescent in situ hybridization and may shed new light

60 staggered by 1, 3, or 5 weeks, and two-color fluorescent in situ hybridization and molecular analyses

61 Recent fluorescent in situ hybridization and molecular cloning

62 Fluorescent in situ hybridization and multiplex ligation

63 ncing, single nucleotide polymorphism array, fluorescent in situ hybridization and polymerase chain r

64 , Egyptian Mau, Persian, and nonbreed) using fluorescent in situ hybridization and radiation hybrid m

65 Here we use combined fluorescent in situ hybridization and secondary ion mass

66 Affymetrix microarrays and a combination of fluorescent in situ hybridization and single nucleotide

67 Fluorescent in situ hybridization and synaptonemal compl

68 d in 6 patients, with 4 also in remission by fluorescent in situ hybridization and/or reverse-transcr

69 We used fluorescent in-situ hybridization and confocal microscop

70 f tumor metaphases using sequential telomere fluorescent in-situ hybridization and spectral karyotypi

71 d on chromosome 15q15-21.1, as determined by fluorescent in situ hybridization, and between markers D

72 dded (FFPE) tissue for immunohistochemistry, fluorescent in situ hybridization, and direct sequencing

73 rcinoma, had ROS1 rearrangement according to fluorescent in situ hybridization, and had received criz

74 ocations were analyzed by RNA sequencing and fluorescent in situ hybridization, and novel translocati

75 tatus, cytogenetic abnormalities assessed by fluorescent in situ hybridization, and Z-chain-associate

76 We used a fluorescent in situ hybridization assay to evaluate CD27

77 used an immunoglobulin (Ig)H locus-specific fluorescent in situ hybridization assay to unequivocally

78 A combination of fluorescent in situ hybridization, BAC transgenesis, and

79 leukocytes by a high-throughput quantitative fluorescent in situ hybridization-based technology.

80 ame upregulated and monoallelic as judged by fluorescent in situ hybridization, but early Xist signal

81 Fluorescent in situ hybridization can be completed in a

82 Messenger RNA detection, fluorescent in situ hybridization, cell sorting, and oli

83 ration, labeling of chromosome-specific DNA, fluorescent in situ hybridization (chromosome painting)

84 in human cells using chromosome-orientation fluorescent in situ hybridization (CO-FISH).

85 By quantitative fluorescent in situ hybridization combined with immunofl

86 Using SIV-specific fluorescent in situ hybridization combined with immunofl

87 Fluorescent in situ hybridization combined with immunofl

88 molecular cytogenetic techniques, including fluorescent in situ hybridization, comparative genomic h

89 Fluorescent in situ hybridization confirmed amplificatio

90 Fluorescent in situ hybridization confirmed the existenc

91 We show here, by means of fluorescent in situ hybridization coupled with tyramide

92 Fluorescent in situ hybridization data were available in

93 hromosome clones containing either D4 or D5, fluorescent in situ hybridization defined a single regio

94 Cell fate analysis using Y-chromosome fluorescent in situ hybridization demonstrated rare cell

95 Flow cytometric fluorescent in situ hybridization demonstrated that CD56

96 Consistent with this hypothesis, fluorescent in situ hybridization demonstrates that a ci

97 Direct analysis of telomeres in HSCs by fluorescent in situ hybridization during serial transpla

98 patient's marrow yielded no metaphases, but fluorescent in situ hybridization evaluation approximate

99 Fluorescent in situ hybridization experiments indicate t

100 tion enrichment technique and filter-adapted fluorescent in situ hybridization (FA-FISH), a FISH meth

101 Fluorescent in situ hybridization (FISH) allows the quan

102 ublished mapping of randomly chosen genes by fluorescent in situ hybridization (FISH) also shows a si

103 Fluorescent in situ hybridization (FISH) analyses from 1

104 ulation of donor-derived T cells followed by fluorescent in situ hybridization (FISH) analysis of tel

105 k movement and three-dimensional RNA and DNA fluorescent in situ hybridization (FISH) analysis of the

106 Fluorescent in situ hybridization (FISH) analysis reveal

107 Fluorescent in situ hybridization (FISH) analysis showed

108 on into the CHO cell genome was confirmed by fluorescent in situ hybridization (FISH) analysis.

109 f the biofilm for nitrifiers, as observed by fluorescent in situ hybridization (FISH) analysis.

110 ance rate between immunohistochemistry (IHC)/fluorescent in situ hybridization (FISH) and GHI RT-PCR

111 ry cirrhosis, hepatitis C, and in normals by fluorescent in situ hybridization (FISH) and immunofluor

112 To address these issues, we used single-RNA fluorescent in situ hybridization (FISH) and measured th

113 Fluorescent in situ hybridization (FISH) and quantitativ

114 ed monoallelic or biallelic A20 deletions by fluorescent in situ hybridization (FISH) and/or SNP-arra

115 study, we assessed a commercially available fluorescent in situ hybridization (FISH) assay (seaFAST

116 was correlated with immunohistochemical and fluorescent in situ hybridization (FISH) assay results.

117 n clinics through direct visualization via a fluorescent in situ hybridization (FISH) assay, which ca

118 determined by immunohistochemistry (IHC) and fluorescent in situ hybridization (FISH) at a central la

119 genetic abnormalities detected by interphase fluorescent in situ hybridization (FISH) can identify pa

120 addition, arrays visualized by GFP-GR or DNA fluorescent in situ hybridization (FISH) decondensed to

121 n vitro culture of rye anthers combined with fluorescent in situ hybridization (FISH) detection of te

122 lotinib was suggested among 43 patients with fluorescent in situ hybridization (FISH) EGFR-negative t

123 Fluorescent in situ hybridization (FISH) experiments sho

124 otype arrays, Giemsa banding (G-banding) and fluorescent in situ hybridization (FISH) experiments, mi

125 We performed fluorescent in situ hybridization (FISH) for 16q23 abnor

126 Fluorescent in situ hybridization (FISH) for mouse and h

127 and MUM1/interferon regulatory factor 4, and fluorescent in situ hybridization (FISH) for MYC and BCL

128 Histological categorization, fluorescent in situ hybridization (FISH) for the alpha s

129 We further compared q-PCR to fluorescent in situ hybridization (FISH) for the detecti

130 nting of transcripts within single cells via fluorescent in situ hybridization (FISH) has allowed res

131 receptor (EGFR) gene copy number detected by fluorescent in situ hybridization (FISH) has proven to b

132 sts published immunohistochemistry (IHC) and fluorescent in situ hybridization (FISH) HER2 testing gu

133 Then, postexpansion, fluorescent in situ hybridization (FISH) imaging of RNA

134 gene copy numbers per cell were evaluated by fluorescent in situ hybridization (FISH) in 102 NSCLC pa

135 Fluorescent in situ hybridization (FISH) is a method tha

136 Fluorescent in situ hybridization (FISH) of pachytene ce

137 Candida albicans peptide nucleic acid (PNA) fluorescent in situ hybridization (FISH) probe.

138 bean repetitive DNA to develop a cocktail of fluorescent in situ hybridization (FISH) probes that cou

139 taining of > 30% of invasive tumor cells), a fluorescent in situ hybridization (FISH) result of more

140 Fluorescent in situ hybridization (FISH) revealed T. den

141 epletion causes an increase in multitelomere fluorescent in situ hybridization (FISH) signals similar

142 Recent molecular phylogenetic and fluorescent in situ hybridization (FISH) studies suggest

143 We performed an interphase fluorescent in situ hybridization (FISH) study to determ

144 We developed a robust multiplex fluorescent in situ hybridization (FISH) technique in ar

145 Fluorescent in situ hybridization (FISH) techniques are

146 bination of magnetic cell sorting (MACS) and fluorescent in situ hybridization (FISH) techniques was

147 Utilizing fluorescent in situ hybridization (FISH) techniques, we

148 A commercially available rapid fluorescent in situ hybridization (FISH) test, (seaFAST

149 d determined by radiation hybrid mapping and fluorescent in situ hybridization (FISH) that the gene i

150 taphases were studied by means of interphase fluorescent in situ hybridization (FISH) to detect IgH t

151 n 86 tumor samples from 82 HNSCC patients by fluorescent in situ hybridization (FISH) to determine EG

152 In the mouse, we used fluorescent in situ hybridization (FISH) to document tha

153 ied fusion genes are recurrent, we performed fluorescent in situ hybridization (FISH) to screen 196 i

154 approach based on multicolor single-molecule fluorescent in situ hybridization (FISH) to study the co

155 res (QDs) make them desirable candidates for fluorescent in situ hybridization (FISH) to study the ex

156 Ialpha and HER2 copy number were measured by fluorescent in situ hybridization (FISH) using a triple-

157 EGFR CNG was determined by fluorescent in situ hybridization (FISH) using prespecif

158 Physical mapping of BACs by fluorescent in situ hybridization (FISH) was used to ana

159 By fluorescent in situ hybridization (FISH) we showed that

160 We then used fluorescent in situ hybridization (FISH) with 16S rRNA p

161 = 13) and controls (n = 38) were examined by fluorescent in situ hybridization (FISH) with a eubacter

162 Using fluorescent in situ hybridization (FISH) with riboprobes

163 growth factor receptor 2 (HER2) to CEP17 by fluorescent in situ hybridization (FISH) with the centro

164 ization (aCGH), quantitative PCR (qPCR), and fluorescent in situ hybridization (FISH), achieving a va

165 By fluorescent in situ hybridization (FISH), all 3 transloc

166 Western blot analyses, immunohistochemistry, fluorescent in situ hybridization (FISH), and functional

167 EGFR immunohistochemistry (IHC), fluorescent in situ hybridization (FISH), and mutation a

168 de chromosome conformation capture analysis, fluorescent in situ hybridization (FISH), and RNA-seq to

169 We analyzed CCND and RB status in CTCL using fluorescent in situ hybridization (FISH), immunohistoche

170 bosomal RNA (rRNA) precursor-analyzed by RNA fluorescent in situ hybridization (FISH), Northern blots

171 s seen between tumors with normal HER1, HER2 fluorescent in situ hybridization (FISH), or HER3 levels

172 Duplications were verified by fluorescent in situ hybridization (FISH), PCR on isolate

173 Using fluorescent in situ hybridization (FISH), we assayed pai

174 Using slot-blot and fluorescent in situ hybridization (FISH), we found no ev

175 Using fluorescent in situ hybridization (FISH), we mapped the

176 h HER-2/neu immunohistochemistry (IHC) 3+ or fluorescent in situ hybridization (FISH)-amplified breas

177 In this study, we derived a fluorescent in situ hybridization (FISH)-based trisomy i

178 on (array CGH), quantitative PCR (qPCR), and fluorescent in situ hybridization (FISH).

179 hromosomes (BACs) from B. rapa as probes for fluorescent in situ hybridization (FISH).

180 hemistry (IHC), and EGFR gene copy number by fluorescent in situ hybridization (FISH).

181 chromosome 7 copy numbers were identified by fluorescent in situ hybridization (FISH).

182 h-specimens from 18 prescreened women, using fluorescent in situ hybridization (FISH).

183 u and T cell receptor (TCR)-beta genes using fluorescent in situ hybridization (FISH).

184 al-time quantitative RT-PCR (TaqMan) and RNA-fluorescent in situ hybridization (FISH).

185 ctor receptor 2 gene (HER2) amplification by fluorescent in situ hybridization (FISH).

186 in tissue by immunohistochemistry (IHC) and fluorescent in situ hybridization (FISH).

187 sed for centromeric sequences using standard fluorescent in situ hybridization (FISH).

188 transcriptase-polymerase chain reaction and fluorescent in situ hybridization (FISH); whereas, in th

189 by comparative genomic hybridization (CGH), fluorescent in-situ hybridization (FISH), array-CGH, qua

190 isatellite polymorphism in the 5' UTR and by fluorescent in-situ hybridization (FISH).

191 Spectral karyotyping (SKY) and fluorescent-in-situ hybridization (FISH) demonstrated co

192 ed a novel microfluidic approach, where flow fluorescent in situ hybridization (flow-FISH) using lock

193 Tumor tissue was analyzed by fluorescent in situ hybridization for 1p and 19q deletio

194 EML4-ALK was identified by using fluorescent in situ hybridization for ALK rearrangements

195 Fluorescent in situ hybridization for CEP17, HER2, and T

196 ing with the use of high-resolution banding, fluorescent in situ hybridization for chromosome 22q11 d

197 and HER2 status, which was then confirmed by fluorescent in situ hybridization for IHC/ICC 2+ and 3+

198 unohistochemistry for MYC and BCL2, and with fluorescent in situ hybridization for MYC, BCL2, and BCL

199 ed using immunohistochemistry and interphase fluorescent in situ hybridization for MYC, BCL6, and t(1

200 Fluorescent in situ hybridization for specific genetic a

201 Using flow cytometry and fluorescent in situ hybridization for the intestinal ste

202 Donor cell engraftment was confirmed using fluorescent in situ hybridization for the porcine X chro

203 Fluorescent in situ hybridization for the X and Y chromo

204 ning with a hepatocyte-specific antibody and fluorescent in situ hybridization for visualization of Y

205 Fluorescent in situ hybridizations have localized the tr

206 y (utilizing neuron-specific antibodies) and fluorescent in situ hybridization histochemistry to sear

207 Interphase fluorescent in situ hybridization identified a proteolip

208 n CD138-purified myeloma cells by interphase fluorescent in situ hybridization (iFISH) alongside clin

209 a high-precision, high-throughput, automated fluorescent in situ hybridization imaging pipeline, for

210 qMan real-time polymerase chain reaction and fluorescent in situ hybridization imaging were used to s

211 alterations in these tumors were analyzed by fluorescent in situ hybridization, immunohistochemistry,

212 hromosomal patterns in inflammatory cells by fluorescent in situ hybridization/immunohistochemistry c

213 TL was measured by multicolor flow cytometry-fluorescent in situ hybridization in 12 leukocyte subpop

214 on t(5:6)(G1;F2) was identified by two-color fluorescent in situ hybridization in all tumors, and, us

215 se chain reaction, and TMPRSS2-ERG status by fluorescent in situ hybridization in available tissues.

216 testes than in ovaries was also detected by fluorescent in situ hybridization in G. f.

217 diversity of form, 16S rRNA gene surveys and fluorescent in situ hybridizations indicate that these b

218 rse transcription polymerase chain reaction, fluorescent in situ hybridization, lentiviral overexpres

219 Both radiation hybrid mapping and fluorescent in situ hybridization localized the gene to

220 ray-based comparative genomic hybridization, fluorescent in situ hybridization, loss of heterozygosit

221 ing the cost of procedures such as multiplex fluorescent in situ hybridization (M-FISH) by 100-200 fo

222 etic alignment of the RH map was improved by fluorescent in situ hybridization mapping of six of the

223 echniques such as digital image analysis and fluorescent in-situ hybridization may improve the cytolo

224 Here, we report a multiplexed fluorescent in situ hybridization method based on orthog

225 Fluorescent in situ hybridization of CI-activated CML ce

226 Fluorescent in situ hybridization of the Y chromosome re

227 ated from integrated viral DNA by performing fluorescent in situ hybridization on cells in which stre

228 Two-color fluorescent in situ hybridization on dissociated retinas

229 High-resolution fluorescent in situ hybridization on hemophilia A dog DN

230 Fluorescent in situ hybridization on surgical specimens

231 cal analysis [IHC]), and gene amplification (fluorescent in situ hybridization or chromogenic in situ

232 e presence of chromosome 17 and p53 genes by fluorescent in situ hybridization, p53 mutations by DNA

233 us agar (SSA), and by a peptide nucleic acid fluorescent in situ hybridization (PNA FISH) assay were

234 bicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization (PNA FISH) method, a r

235 use of subculture, GBS peptide nucleic acid fluorescent in situ hybridization (PNA FISH), and GBS PC

236 vo was visualized using peptide nucleic acid fluorescent in situ hybridization (PNA-FISH) and confoca

237 -positive tumors (immunohistochemistry 3+ or fluorescent in situ hybridization positive) by retrospec

238 ents stained with both a strain CJ2-specific fluorescent in situ hybridization probe and a polyclonal

239 Instead, fluorescent in situ hybridization probes that distinguis

240 Double fluorescent in situ hybridization revealed a high level

241 er, analysis of poly(A)+ RNA localization by fluorescent in situ hybridization revealed a speckled pa

242 Fluorescent in situ hybridization revealed no associatio

243 e neurons were identified in the graft site, fluorescent in situ hybridization revealed polyploidy in

244 Finally, analysis by fluorescent in situ hybridization revealed that promoter

245 Fluorescent in situ hybridization revealed that stress g

246 Fluorescent in situ hybridization revealed that the homo

247 Analysis by Southern hybridization and fluorescent in situ hybridization revealed the clustered

248 Sequential barcoded fluorescent in situ hybridization (seqFISH) allows large

249 Dual fluorescent in situ hybridization showed no coexpression

250 Fluorescent in situ hybridization showed that each of th

251 Furthermore, using single-molecule RNA fluorescent in situ hybridization (smRNA FISH), we show

252 ksA via an operon fusion and single molecule fluorescent in situ hybridization studies.

253 id DNA sequence divergence, we observed, via fluorescent in situ hybridization, substantial chromosom

254 DE-induced 3p21.3 aberrations were scored by fluorescent in situ hybridization technique in 1000 inte

255 robust large-volume, four-color quantitative fluorescent in situ hybridization technique to measure t

256 Using the fluorescent in situ hybridization technique, we demonstr

257 ions were stained for X and Y chromosomes by fluorescent in situ hybridization technique.

258 Fluorescent in-situ hybridization technique, which uses

259 mucosa as measured by DNA fingerprinting and fluorescent in situ hybridization techniques.

260 enomic hybridization is replacing the use of fluorescent in-situ hybridization techniques for the chi

261 genetic abnormalities assessed by interphase fluorescent in situ hybridization testing, 25(OH)D insuf

262 HER2 positivity, as defined by IHC or fluorescent in situ hybridization testing, remains an im

263 We have confirmed by fluorescent in situ hybridization that MBD1 and MBD2 bra

264 The human mammaglobin gene is localized by fluorescent in situ hybridization to chromosome 11 band

265 array comparative genomic hybridization and fluorescent in situ hybridization to detect and spatiall

266 We used cytoplasmic Ig-enhanced interphase fluorescent in situ hybridization to detect deletions (1

267 We report here the use of fluorescent in situ hybridization to examine the chromos

268 We used sensitive multicolor fluorescent in situ hybridization to generate a detailed

269 pted in translocation heterozygotes, we used fluorescent in situ hybridization to measure the extent

270 Fluorescent in situ hybridization to mitotic and pollen

271 mosomal instability in this disease, we used fluorescent in situ hybridization to monitor copy number

272 Using fluorescent in situ hybridization to monitor segment 7 m

273 immunofluorescent cell-surface staining and fluorescent in situ hybridization to quantify both EBV c

274 Adolphe et al. use single molecule fluorescent in situ hybridization to show quantitatively

275 We have used fluorescent in-situ hybridization to establish the chrom

276 Fluorescent in situ hybridization using cosmid probes ma

277 IGF1R gene copy number was assessed by fluorescent in situ hybridization using customized probe

278 cent normal epithelial cells by quantitative fluorescent in situ hybridization using paraffin-embedde

279 ER-2 testing include immunohistochemistry or fluorescent in situ hybridization using tumor tissue.

280 Fluorescent in situ hybridization, using an alpha satell

281 Fluorescent in situ hybridization was performed to deter

282 To test this hypothesis, multiplex fluorescent in situ hybridization was used to characteri

283 High-throughput fluorescent in situ hybridization was used to detect IGH

284 ive of a switch in AA transmitter phenotype, fluorescent in situ hybridization was used to detect vGl

285 Fluorescent in situ hybridization was used to examine th

286 Using fluorescent in situ hybridization we have mapped Cds1 an

287 Using fluorescent in situ hybridization we mapped Zfr to chrom

288 itative PCR (qPCR), droplet digital PCR, and fluorescent in situ hybridization, we could demonstrate

289 digital chromosome conformation capture and fluorescent in situ hybridization, we found that a Droso

290 By live imaging and semiquantitative fluorescent in situ hybridization, we show that Klar bet

291 Using fluorescent in situ hybridization, we show that Lungkine

292 Using both immunocytochemistry and fluorescent in situ hybridization, we show that neurons

293 s as determined with immunohistochemistry or fluorescent in situ hybridization were evaluated in 56 w

294 ease, and HER2 overexpression (determined by fluorescent in situ hybridization) were treated with six

295 Fluorescent in situ hybridization with a T. whipplei-spe

296 Here, we employ fluorescent in situ hybridization with cosmid probes to

297 Fluorescent in situ hybridization with Fcr1 probes stain

298 We used fluorescent in situ hybridization with probes for nascen

299 Cytogenetic aberrations were confirmed using fluorescent in situ hybridization with probes for the MD

300 he c-myc/TGF-alpha double-transgenic mice by fluorescent in situ hybridization with whole chromosome